| View |
|
DRP-11645-03
|
Paracetamol
|
Acetatree
|
500 mg
|
Tablet
|
Analgesic/Antipyretic (Anilide)
|
Pharmatechnica Laboratory Inc.
|
Philippines
|
CLIDP Conversion
|
01 March 2024
|
15 October 2027
|
| View |
|
DRP-11661-06
|
Propofol
|
Folenda
|
10 mg/mL
|
Emulsion for Injection (I.V.)
|
General Anesthetic
|
Daewon Pharm. Co., Ltd.
|
Korea
|
CLIDP Conversion
|
23 January 2024
|
07 April 2027
|
| View |
|
DRP-11704-01
|
Ascorbic acid (as Sodium Ascorbate)
|
Bamvit-C
|
500 mg
|
Capsule
|
Vitamin
|
Pharmatechnica Laboratory Inc.
|
Philippines
|
CLIDP Conversion
|
12 February 2024
|
08 December 2026
|
| View |
|
DRP-11704-02
|
Ascorbic acid (as Sodium Ascorbate)
|
Ascorbtree
|
500 mg
|
Capsule
|
Vitamin
|
Pharmatechnica Laboratory Inc.
|
Philippines
|
CLIDP Conversion
|
01 March 2024
|
08 December 2026
|
| View |
|
DRP-11801-05
|
Cefuroxime (as sodium)
|
Santecef
|
750 mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporin)
|
Furen Pharmaceutical Group Co., Ltd.
|
China
|
CLIDP Conversion
|
03 March 2024
|
29 April 2027
|
| View |
|
DRP-11809-01
|
Mesna
|
Eruna
|
100 mg/mL (400 mg/4 mL)
|
Solution for Injection (I.V.)
|
Antineoplastic
|
Bruck Pharma Private Limited
|
India
|
CLIDP Conversion
|
01 February 2024
|
02 May 2027
|
| View |
|
DRP-11812-03
|
Ascorbic Acid + Zinc
|
Ascorbtree +
|
500 mg (equivalent to 562.54 mg Sodium Ascorbate) / 10 mg (equivalent to 27.5 mg Zinc Sulfate)
|
Caplet
|
Vitamin & Mineral
|
Pharmatechnica Laboratory Inc.
|
Philippines
|
CLIDP Conversion
|
01 March 2024
|
02 May 2027
|
| View |
|
DRP-11836-02
|
Methotrexate
|
Trexiglob
|
100 mg/mL
|
Solution for Injection (IM/IV)
|
Antineoplastic Agent (Folic Acid Analogue)
|
Bruck Pharma Private Limited
|
India
|
CLIDP Conversion
|
06 February 2024
|
05 May 2027
|
| View |
|
DRP-11849-02
|
Dutasteride + Tamsulosin Hydrochloride
|
Kligflow
|
500 mcg/400 mcg
|
Capsule
|
Alpha-adrenoreceptor Antagonists
|
Sapphire Lifesciences Pvt. Ltd
|
India
|
CLIDP Conversion
|
26 February 2024
|
10 May 2027
|
| View |
|
DRP-11865-01
|
Cefuroxime (as axetil)
|
None
|
500 mg
|
Tablet
|
Antibacterial (Cephalosporin)
|
Glaxo Operations UK Limited Trading as Glaxo Wellcome Operations
|
United Kingdom
|
CLIDP Conversion
|
14 February 2024
|
25 September 2025
|
| View |
|
DRP-11882-02
|
Salbutamol (as sulfate) + Ipratropium (as bromide)
|
Duodair
|
2.5 mg/500 mcg per 2.5 mL
|
Solution for Inhalation
|
Adrenergics in combination with anticholinergic
|
Ahlcon Parenterals (India) Limited
|
India
|
CLIDP Conversion
|
01 March 2024
|
16 May 2027
|
| View |
|
DRP-11894-01
|
Montelukast (as sodium) + Levocetirizine hydrochloride
|
None
|
10 mg/5 mg
|
Film-Coated Tablet
|
Leukotriene Receptor Antagonist-Antihistamine Combination
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
26 February 2024
|
17 May 2027
|
| View |
|
DRP-11973-01
|
Oxaliplatin
|
Oxzaritine
|
2 mg/ mL (50 mg/ 25 mL)
|
Concentrate Solution for IV Infusion
|
Antineoplastic agent
|
Admac Lifesciences
|
India
|
CLIDP Conversion
|
23 January 2024
|
26 May 2027
|
| View |
|
DRP-12059-05
|
Sitagliptin (as Phosphate Monohydrate) - Metformin Hydrochloride
|
Sitaguard-M
|
50 mg/ 1 g
|
Film-Coated Tablet
|
Oral Hypoglycemic Agent (Dipeptidyl Peptidase 4 (DPP-4) Inhibitor/ Biguanide
|
Theon Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
16 January 2024
|
06 June 2027
|
| View |
|
DRP-12192-01
|
Co-Amoxiclav
|
Asyclav
|
457 mg/5 mL
|
Powder For Oral Suspension
|
Antibacterial (Penicillin)
|
J.M. Tolmann Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
02 February 2024
|
02 September 2027
|
| View |
|
DRP-12200-01
|
Rosuvastatin (as calcium)
|
Rosutech
|
20 mg
|
Film-Coated Tablet
|
HMG CoA reductase inhibitor
|
Fredun Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
14 February 2024
|
29 June 2027
|
| View |
|
DRP-12201-02
|
Rosuvastatin (as calcium)
|
Rosutech
|
10 mg
|
Film-Coated Tablet
|
HMG CoA reductase inhibitor
|
Fredun Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
14 February 2024
|
29 June 2027
|
| View |
|
DRP-12201-03
|
Rosuvastatin (as calcium)
|
Gorovast-10
|
10 mg
|
Film-Coated Tablet
|
HMG CoA reductase inhibitor
|
Fredun Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
14 February 2024
|
29 June 2027
|
| View |
|
DRP-12215-06
|
Acetylcysteine
|
Oxytech
|
600 mg
|
Effervescent Tablet
|
Mucolytic
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
12 February 2024
|
01 July 2027
|
| View |
|
DRP-12215-07
|
Acetylcysteine
|
Biolytic
|
600 mg
|
Effervescent Tablet
|
Mucolytic
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
19 February 2024
|
01 July 2027
|